Hjem › Myasthenia gravis › Illinois
Myasthenia gravis kliniske forsøg i Illinois
12 studier for Myasthenia gravis søger deltagere på steder i Illinois.
Byer i Illinois
Officiel studietekst (engelsk)
A Study to Evaluate the Efficacy and Safety of Rozanolixizumab in Adult Participants With Ocular Myasthenia Gravis
- Mg0038 10105, O'Fallon
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 25. sep. 2026 · NCT07463521Comparative Efficacy of Nipocalimab and Efgartigimod in Participants With Generalized Myasthenia Gravis
- HSHS St. Elizabeth's Hospital, O'Fallon
RekruttererFase 3
Alder 18 til 74 · Alle køn · Opdateret 25. sep. 2026 · NCT07217587A Phase 2 Study to Evaluate Povetacicept in Adults With Generalized Myasthenia Gravis
- HSHS Medical Group - St. Elizabeth's Hospital, O'Fallon
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 11. sep. 2026 · NCT07501702RESET-MG: A Study to Evaluate the Safety and Efficacy of CABA-201 in Participants With Generalized Myasthenia Gravis
- Northwestern Memorial Hospital, Chicago
RekruttererFase 1/2
Alder 18 til 70 · Alle køn · Opdateret 13. aug. 2026 · NCT06359041Study of Aritinercept in Patients With Generalized Myasthenia Gravis
- Aurinia Investigational Site, Chicago
- Aurinia Investigational Site, O'Fallon
RekruttererFase 1/2
Alder 18 til 85 · Alle køn · Opdateret 3. aug. 2026 · NCT07596901Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis
- Site Number - 1054, Schaumburg
RekruttererFase 3
Alder 18 til 80 · Alle køn · Opdateret 30. jul. 2026 · NCT07039916A Study of Telitacicept for the Treatment of Generalized Myasthenia Gravis (UPSTREAM MG)
- Hospital Sisters Health System Medical, O'Fallon
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 18. jun. 2026 · NCT06456580A Study to Investigate OCS Tapering in Adult Participants With Generalized Myasthenia Gravis Treated With Ravulizumab
- Research Site, Chicago
- Research Site, Schaumburg
RekruttererFase 4
Alder 18 og opefter · Alle køn · Opdateret 9. apr. 2026 · NCT07221838Evaluating the Pharmacokinetics, Pharmacodynamics, and Safety of Efgartigimod Administered Intravenously in Children With Generalized Myasthenia Gravis
- Ann and Robert H Lurie Children's Hospital of Chicago - Main Hospital, Chicago
RekruttererFase 2/3
Alder 2 til 18 · Alle køn · Opdateret 18. feb. 2026 · NCT04833894A Non-interventional, Post-authorisation Safety Study of Patients Treated With Efgartigimod Alfa
- Prairie Education and Research Cooperative and HSHS Medical Group, O'Fallon
RekruttererObservationsstudie
Alder 18 og opefter · Alle køn · Opdateret 17. feb. 2026 · NCT06298565Vitaccess Real MG Registry
- HSHS St. Elizabeth's Hospital, O'Fallon
RekruttererObservationsstudie
Alder 18 og opefter · Alle køn · Opdateret 29. jul. 2025 · NCT06064461Validation and Scaling of Screening Program for Undiagnosed Myasthenia Gravis-Social Media Campaign Paired With a Self-moderated Assessment
- ZS Associates, Evanston
RekruttererObservationsstudieFrivillige med god helbredstilstand velkomne
Alder 18 og opefter · Alle køn · Opdateret 10. mar. 2025 · NCT06866483Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.